Enhancing Chemosensitivity of Breast Cancer Stem Cells by Down Regulating SOX2 and ABCG2 Using Wedelolactone-Encapsulated Nanoparticles

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-18-0409
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

ERβ Alters the Chemosensitivity of Luminal Breast Cancer Cells by Regulating P53 Function

Oncotarget
Oncology
2018English

MiR-519d Impedes Cisplatin-Resistance in Breast Cancer Stem Cells by Down-Regulating the Expression of McL-1

Oncotarget
Oncology
2017English

Celecoxib Targets Breast Cancer Stem Cells by Inhibiting the Synthesis of Prostaglandin E2 and Down-Regulating the WNT Pathway Activity

Oncotarget
Oncology
2017English

Breast Cancer, Side Population Cells and ABCG2 Expression

Cancer Letters
Cancer ResearchOncology
2012English

MicroRNA-224 Inhibits Proliferation and Migration of Breast Cancer Cells by Down-Regulating Frizzled 5 Expression

Oncotarget
Oncology
2016English

Breast Cancer Resistance Protein BCRP/ABCG2 Regulatory microRNAs (Hsa-miR-328, -519c and -520h) and Their Differential Expression in Stem-Like ABCG2+ Cancer Cells

Biochemical Pharmacology
BiochemistryPharmacology
2011English

Effect of NOS1 Regulating ABCG2 Expression on Proliferation and Apoptosis of Cervical Cancer Cells

Oncology Letters
Cancer ResearchOncology
2018English

Wedelolactone Inhibits Breast Cancer-Induced Osteoclastogenesis by Decreasing Akt/mTOR Signaling

International Journal of Oncology
Cancer ResearchOncology
2014English

Breast Cancer Stem Cells

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy